AU535052B2 - 9-substituted-hypoxanthine derivatives - Google Patents

9-substituted-hypoxanthine derivatives

Info

Publication number
AU535052B2
AU535052B2 AU68025/81A AU6802581A AU535052B2 AU 535052 B2 AU535052 B2 AU 535052B2 AU 68025/81 A AU68025/81 A AU 68025/81A AU 6802581 A AU6802581 A AU 6802581A AU 535052 B2 AU535052 B2 AU 535052B2
Authority
AU
Australia
Prior art keywords
acid
sup
compounds
unsubstituted
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU68025/81A
Other languages
English (en)
Other versions
AU6802581A (en
Inventor
Alfredo Giner-Sorolla
Alvin Guttag
Lionel Norton Simon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Newport Pharmaceuticals International Inc
Memorial Sloan Kettering Cancer Center
Original Assignee
NEWPORT PHARMACEUTICALS
Institute for Cancer Research
Memorial Sloan Kettering Cancer Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NEWPORT PHARMACEUTICALS, Institute for Cancer Research, Memorial Sloan Kettering Cancer Center filed Critical NEWPORT PHARMACEUTICALS
Publication of AU6802581A publication Critical patent/AU6802581A/en
Application granted granted Critical
Publication of AU535052B2 publication Critical patent/AU535052B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28Oxygen atom
    • C07D473/30Oxygen atom attached in position 6, e.g. hypoxanthine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU68025/81A 1980-03-14 1981-03-03 9-substituted-hypoxanthine derivatives Ceased AU535052B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/130,334 US4340726A (en) 1980-03-14 1980-03-14 Esters
US130334 1980-03-14

Publications (2)

Publication Number Publication Date
AU6802581A AU6802581A (en) 1981-09-17
AU535052B2 true AU535052B2 (en) 1984-03-01

Family

ID=22444200

Family Applications (1)

Application Number Title Priority Date Filing Date
AU68025/81A Ceased AU535052B2 (en) 1980-03-14 1981-03-03 9-substituted-hypoxanthine derivatives

Country Status (26)

Country Link
US (1) US4340726A (cg-RX-API-DMAC7.html)
EP (1) EP0036077B1 (cg-RX-API-DMAC7.html)
JP (1) JPS572287A (cg-RX-API-DMAC7.html)
KR (1) KR850000320B1 (cg-RX-API-DMAC7.html)
AT (1) ATE8995T1 (cg-RX-API-DMAC7.html)
AU (1) AU535052B2 (cg-RX-API-DMAC7.html)
CA (1) CA1159827A (cg-RX-API-DMAC7.html)
CS (1) CS235514B2 (cg-RX-API-DMAC7.html)
DD (1) DD156813A5 (cg-RX-API-DMAC7.html)
DE (1) DE3165476D1 (cg-RX-API-DMAC7.html)
DK (1) DK154768C (cg-RX-API-DMAC7.html)
ES (1) ES8202825A1 (cg-RX-API-DMAC7.html)
FI (1) FI67848C (cg-RX-API-DMAC7.html)
GR (1) GR74807B (cg-RX-API-DMAC7.html)
HU (1) HU187324B (cg-RX-API-DMAC7.html)
IE (1) IE51019B1 (cg-RX-API-DMAC7.html)
IL (1) IL62258A (cg-RX-API-DMAC7.html)
IN (1) IN155441B (cg-RX-API-DMAC7.html)
NO (1) NO155579C (cg-RX-API-DMAC7.html)
NZ (1) NZ196295A (cg-RX-API-DMAC7.html)
PH (1) PH19148A (cg-RX-API-DMAC7.html)
PL (1) PL129094B1 (cg-RX-API-DMAC7.html)
PT (1) PT72665B (cg-RX-API-DMAC7.html)
RO (1) RO82509A (cg-RX-API-DMAC7.html)
YU (1) YU41973B (cg-RX-API-DMAC7.html)
ZA (1) ZA811181B (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4423050A (en) * 1981-05-21 1983-12-27 Syntex (U.S.A.) Inc. 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
JPS58135878A (ja) * 1981-09-22 1983-08-12 Suntory Ltd 新規アイラントン誘導体及びその製造法
AU564576B2 (en) * 1981-09-24 1987-08-20 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Purine derivatives
US4451478A (en) * 1982-03-12 1984-05-29 Newport Pharmaceuticals International, Inc. Imidazole compounds
US4609662A (en) * 1982-10-14 1986-09-02 Burroughs Wellcome Co. Method for using purine derivatives
HUT36464A (en) * 1983-05-24 1985-09-30 Newport Pharmaceuticals Process for producing erythro-4-amino-3-/2-hydroxy-3-alkyl/-imidazol-5-carboxamide
JP3005959B2 (ja) * 1989-03-31 2000-02-07 ヤンマー農機株式会社 乗用田植機における植付部伝動構造
US5614504A (en) * 1990-08-01 1997-03-25 The University Of South Florida Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
US6420374B1 (en) 1990-11-30 2002-07-16 Fred Hutchinson Cancer Research Center Use of xanthines as immunosuppressants and to inhibit allograft reactions
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
BE1008977A5 (fr) * 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
US6303617B1 (en) 1998-05-04 2001-10-16 Neotherapeutics, Inc. Serotonin-like 9-substituted hypoxanthine and methods of use
US6297226B1 (en) 1999-10-15 2001-10-02 Neotherapeutics, Inc. Synthesis and methods of use of 9-substituted guanine derivatives
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
ATE499103T1 (de) 2000-07-07 2011-03-15 Spectrum Pharmaceuticals Inc Verfahren zur behandlung von arzneimittelinduzierter peripherer neuropathie und verwandten krankheitsformen
US6759427B2 (en) 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
CA2540598C (en) * 2003-10-03 2013-09-24 3M Innovative Properties Company Pyrazolopyridines and analogs thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2940966A (en) * 1958-05-15 1960-06-14 Daniel R Bullard Glucoside of 2-amino-4-hydroxy-6-(1', 2'-dihydroxypropyl)-pteridine
US3862189A (en) * 1973-08-14 1975-01-21 Warner Lambert Co Aralkyl-substituted purines and pyrimidines as antianginal bronchodilator agents
US4138562A (en) * 1977-02-09 1979-02-06 The Regents Of The University Of Minnesota Adenosine deaminase resistant antiviral purine nucleosides and method of preparation
DE2714883A1 (de) * 1977-04-02 1978-10-12 Basf Ag Nicht-glykosidische theophyllin- zucker-derivate
JPS55113786A (en) * 1979-02-23 1980-09-02 Toyo Jozo Co Ltd Novel substance, nepranosin b or f and its preparation
US4221909A (en) * 1978-09-15 1980-09-09 Sloan-Kettering Institute For Cancer Research P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines
US4221910A (en) * 1978-09-15 1980-09-09 Newport Pharmaceuticals International, Inc. 9-(Hydroxy alkyl)purines
US4221794A (en) * 1979-06-21 1980-09-09 Newport Pharmaceuticals International, Inc. Method of imparting immunomodulating and antiviral activity

Also Published As

Publication number Publication date
KR850000320B1 (ko) 1985-03-20
NO810723L (no) 1981-09-15
IE810552L (en) 1981-09-14
DK154768B (da) 1988-12-19
AU6802581A (en) 1981-09-17
PH19148A (en) 1986-01-15
IL62258A (en) 1984-12-31
DE3165476D1 (en) 1984-09-20
EP0036077A3 (en) 1982-01-13
CS235514B2 (en) 1985-05-15
FI67848B (fi) 1985-02-28
ZA811181B (en) 1982-01-27
ES500321A0 (es) 1982-03-01
JPH031311B2 (cg-RX-API-DMAC7.html) 1991-01-10
RO82509A (ro) 1983-09-26
JPS572287A (en) 1982-01-07
EP0036077A2 (en) 1981-09-23
GR74807B (cg-RX-API-DMAC7.html) 1984-08-12
FI810774L (fi) 1981-09-15
CA1159827A (en) 1984-01-03
US4340726A (en) 1982-07-20
ATE8995T1 (de) 1984-09-15
YU41973B (en) 1988-04-30
ES8202825A1 (es) 1982-03-01
KR830005224A (ko) 1983-08-03
PT72665A (en) 1981-04-01
DK154768C (da) 1989-06-19
NZ196295A (en) 1983-09-02
HU187324B (en) 1985-12-28
NO155579C (no) 1987-04-22
NO155579B (no) 1987-01-12
EP0036077B1 (en) 1984-08-15
DK115081A (da) 1981-09-15
IN155441B (cg-RX-API-DMAC7.html) 1985-02-02
RO82509B (ro) 1983-08-30
PL129094B1 (en) 1984-03-31
PL230115A1 (cg-RX-API-DMAC7.html) 1981-11-13
IE51019B1 (en) 1986-09-03
DD156813A5 (de) 1982-09-22
PT72665B (en) 1982-06-08
YU65181A (en) 1984-02-29
FI67848C (fi) 1985-06-10

Similar Documents

Publication Publication Date Title
AU535052B2 (en) 9-substituted-hypoxanthine derivatives
UA6345A1 (uk) Спосіб одержання похідного авермектіна
WO1991004754A3 (en) Illudin analogs as anti-tumor agents
ES465291A1 (es) Procedimiento para preparar esteres de acidos ciclopropano- carboxilicos con alcoholes bencilicos halogenados.
ES8107306A1 (es) Un metodo mejorado para producir y acumular el antibiotico c-15003 p-3
NZ211954A (en) Reaction products of alkenylsuccinic acid, esters or anhydrides with aromatic amines and lubricant compositions thereof
KR860000236A (ko) 유기산의 트리테르페닐의 에스테르의 제조방법
GB1303038A (en) Pleuromutilin derivatives
AU547968B2 (en) Ml-236b derivatives i.e. alactone and the corresponding free hydroxy-carboxylic acid
ATE145346T1 (de) Endgruppenverschlossene antischaummittel
EP0151419A3 (en) Method of preparing d(-)-beta-hydroxyisobutyric acid by fermentation
FR2409306A1 (fr) Procede de production de l'antibiotique c-15003 p-4 par culture d'un micro-organisme du genre nocardia
GB1268008A (en) ESTERS OF p-BYPHENYLYLACETIC ACID
ES457577A1 (es) Un procedimiento de preparacion de nuevos compuestos de be- ta-lactama.
EP0220892A3 (en) Cold flow improving fuel additive compound and fuel composition containing same
AU680325B2 (en) Process for the carbonylation of an acetylenically unsaturated compound
JPS5661377A (en) Optically active cephaloasporin analog
GB1225082A (cg-RX-API-DMAC7.html)
JPS5492693A (en) Preparation of cephalosporin derivatives